Present morality in parkinson's disease: the ratio of observed to expected deaths with a method to calculate expected deaths
- PMID: 956812
- DOI: 10.1007/BF01249443
Present morality in parkinson's disease: the ratio of observed to expected deaths with a method to calculate expected deaths
Abstract
Excess mortality, i.e. more deaths than expected in a similar normal population, has been reduced in Parkinson's disease by levodopa. A California series and a large collaborative study throughout the United States show the ratio of observed to expected deaths to be normal. In contrast, a New York study was similar patients and a Montreal group of much more severely disabled patients showed greater mortality. The reasons for these differences are unclear, but some variations in results may be attributed to different methods of calculating expected deaths to derive the ratio of observed to expected deaths.
Similar articles
-
Analysis of mortality in pergolide-treated patients with Parkinson's disease.Neuroepidemiology. 1996 Jan-Feb;15(1):26-32. doi: 10.1159/000109886. Neuroepidemiology. 1996. PMID: 8719046
-
Investigation by Parkinson's Disease Research Group of United Kingdom into excess mortality seen with combined levodopa and selegiline treatment in patients with early, mild Parkinson's disease: further results of randomised trial and confidential inquiry.BMJ. 1998 Apr 18;316(7139):1191-6. doi: 10.1136/bmj.316.7139.1191. BMJ. 1998. PMID: 9583926 Free PMC article. Clinical Trial.
-
Changing epidemiology of Parkinson's disease: predicted effects of levodopa treatment.Acta Neurol Scand. 1979 Mar;59(2-3):80-7. doi: 10.1111/j.1600-0404.1979.tb02914.x. Acta Neurol Scand. 1979. PMID: 452843
-
Does levodopa therapy delay death in Parkinson's disease? A review of the evidence.Mov Disord. 1995 May;10(3):250-6. doi: 10.1002/mds.870100303. Mov Disord. 1995. PMID: 7651439 Review.
-
Controversies in the treatment of Parkinson's disease.Curr Opin Neurol. 1996 Aug;9(4):308-13. doi: 10.1097/00019052-199608000-00012. Curr Opin Neurol. 1996. PMID: 8858190 Review.
Cited by
-
Mortality in levodopa-treated Parkinson's disease.Parkinsons Dis. 2014;2014:426976. doi: 10.1155/2014/426976. Epub 2014 Jan 28. Parkinsons Dis. 2014. PMID: 24616821 Free PMC article.
-
A risk-benefit assessment of drugs used in the management of Parkinson's disease.Drug Saf. 1994 Aug;11(2):94-103. doi: 10.2165/00002018-199411020-00004. Drug Saf. 1994. PMID: 7946003 Review.
-
Mortality of patients with Parkinson's disease treated with levodopa.J Neurol. 1977 Oct 7;216(3):147-53. doi: 10.1007/BF00313615. J Neurol. 1977. PMID: 72132
-
Treatment of Parkinson's disease: problems with a progressing disease.J Neural Transm. 1981;51(1-2):161-74. doi: 10.1007/BF01664013. J Neural Transm. 1981. PMID: 7264627
-
Survival and cause of death in a cohort of patients with parkinsonism: possible clues to aetiology?J Neurol Neurosurg Psychiatry. 1995 Mar;58(3):293-9. doi: 10.1136/jnnp.58.3.293. J Neurol Neurosurg Psychiatry. 1995. PMID: 7897409 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources